TPG Biotech to Fund Development of JCR Pharmaceuticals Drug Candidates
3/12/2008 9:30:33 AM
More...
|
Osiris Therapeutics, Inc. (OSIR) to Receive Milestone Payment from JCR Pharmaceuticals
1/7/2008 8:28:21 AM
More...
|
Kissei Pharmaceutical Co., Ltd. And JCR Pharmaceuticals Enter Into Joint Research Agreement For JR-013, Recombinant Human Erythropoietin-Based Renal Anemia Agent
12/27/2005 11:32:27 AM
More...
|
Fuji Pharmaceutical Co., Ltd. And, JCR Pharmaceuticals Dissolve Partnership In Renal Anemia Drug Development
11/14/2005 12:19:07 PM
More...
|
CepTor Corporation (CEPO.OB) To Receive $1.5 Million From JCR Pharmaceuticals Upon IND Filing
10/20/2005 3:05:46 PM
More...
|
Crucell N.V. (CRXL) And DSM Biologics Announce PER.C6 Licensing Agreement With JCR Pharmaceuticals For Protein Production
10/19/2005 5:12:59 PM
More...
|
CepTor Corporation (CEPO.OB) Announces Exclusive License Agreement For Myodur In The Pacific Rim With JCR Pharmaceuticals
10/19/2005 5:12:53 PM
More...
|
Positive Results From Study In Japan Using Antares Pharma, Inc.'s (ANTR) Needle-Free Medi-Jector VISION(R) For The Delivery Of Human Growth Hormone
10/19/2005 5:12:22 PM
More...
|
Fuji Pharmaceutical Co., Ltd., JCR Pharmaceuticals To Enter Into Licensing Agreement For Recombinant Human Erythropoietin-Based Renal Anemia Agent
10/19/2005 5:12:21 PM
More...
|
Antares Pharma, Inc. (ANTR) Announces Launch Of VISION For Use With Human Growth Hormone In Japan
10/19/2005 5:11:26 PM
More...
|
|